Press release content from Business Wire. The AP news staff was not involved in its creation.
CERo Therapeutics Expands Leadership Team with Experts in Cell Therapy Development
April 15, 2021 GMT
SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) Apr 15, 2021
CERo Therapeutics, Inc., a biopharmaceutical company pioneering the development of novel autologous engineered immune cellular therapies, today announced the expansion of the company’s leadership team with the addition of Remus Vezan, M.D., Ph.D. as Chief Medical Officer (CMO) and John Rossi, M. Sci. as Senior Vice President and Head of Translational Medicine. Dr. Vezan and Mr. Rossi have been instrumental in the successful development of marketed CAR T-cell therapies in their prior roles. At CERo, they will lead the company’s clinical development efforts to rapidly advance its T cell engineering platform and next-generation cell therapy products. CERo’s novel approach combines elements of both innate and adaptive immune res
Sofia, 7, gets first Easter egg following life-changing transplant
Sofia Corey had been a kidney patient since shortly after her birth, meaning that due to diet restrictions, she had never had chocolate
Sofia Corey got to taste her first ever Easter egg this weekend. Picture: Conor McCabe Photography
Sun, 04 Apr, 2021 - 15:07
Steve Neville A seven-year-old from Dublin had an Easter Sunday to remember when she got to taste her very first chocolate Easter egg.
Sofia Corey had been a kidney patient since shortly after her birth, meaning that she had never had chocolate due to diet restrictions.
However, during Christmas week last year, she received a life-changing transplant.